viewExactus, Inc.

Exactus launches search for new CEO and appoints Emiliano Aloi interim chief executive

The group also said Bobby Yampolsky, founder of Ceed2Med LLC, the company’s largest shareholder, will assume the duties of interim chairman

Exactus, Inc - Exactus launches search for new CEO following departure of Philip Young
Exactus is pursuing opportunities in hemp-derived CBD products as it builds a US presence

Exactus Inc (OTCMKTS:EXDI), the CBD producer, announced late Wednesday that Emiliano Aloi, the company’s president, will assume the duties of interim CEO and said it has launched a search for a new CEO following the departure of Philip Young.

In a statement, Exactus noted that Aloi has over 15 years of agroindustrial experience with five years of CBD-related experience, including seed selection, cultivation, harvesting and manufacturing. 

READ: Exactus executes its growth strategy following Oregon hemp farm acquisition

“I am extremely excited about all of the progress that Exactus has made since entering the CBD market in January of 2019 and its prospects for the future,” Aloi said.  

“Currently, we have the infrastructure in place to produce quality CBD products starting at the farm all the way to consumer products. My years of experience and strong relationships in the hemp industry will enable us to continue to move the company forward in becoming a leader in this exciting emerging market.”

Exactus also said Bobby Yampolsky, founder of Ceed2Med LLC, the company’s largest shareholder, will assume the duties of interim chairman.

Yampolsky was appointed to the Exactus board in June and has already been instrumental in creating material value through his extensive business network as a serial entrepreneur, the group pointed out.

READ: Exactus finds its new CFO in Kenneth Puzder

Yampolsky noted that the board is looking for a new CEO who can take the CBD company to the next level. 

“We are seeking to enhance our team by adding a senior executive that has led a public company through aggressive growth with deep brand creation and supply chain management experience as well as a global focus.” he said in the statement.

“Our CEO should possess the drive to take our company forward in the rapidly growing hemp industry providing strong consumer branding, pharmaceutical or nutraceutical experience and track record with proven eight-figure sales leadership.”

Exactus, based in Delray Beach, Florida, is pursuing opportunities in hemp-derived CBD products. It is building a US presence, recently acquiring Green Goddess Extracts, a Florida-based contract manufacturer and formulator of hemp and vape products.

Contact the author: [email protected]

Follow him on Twitter @PatrickMGraham

Quick facts: Exactus, Inc.

Price: 0.0526 USD

Market: OTCQB
Market Cap: $2.73 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Exactus, Inc. named herein, including the promotion by the Company of Exactus, Inc. in any Content on the Site, the Company receives from said...


Exactus off to a great start in 2020 signing a number of Hemp contracts

Exactus (OTCQB: EXDI) President Derek Du Chesne joined Steve Darling from Proactive with news the company is seeing a strong start to 2020 with new customers signing purchase orders. Du Chesne also told Proactive about their new hemp buyback program that was put in place to help farmers...

on 06/09/2020

2 min read